MoonLake Immunotherapeutics ( MLTX) - Key Metrics
MLTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.84 | -$0.75 | -$0.75 |
| 2026Q1 | $0 | -$0.98 | -$0.93 | -$0.93 |
| 2025Q4 | $0 | -$0.97 | -$0.91 | -$0.91 |
| 2025Q3 | $0 | -$1.10 | -$0.70 | -$0.70 |
| 2025Q2 | $0 | -$0.87 | -$0.86 | -$0.86 |
MLTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.79 |
| 2026Q1 | 0% | -4.76 |
| 2025Q4 | 0% | -3.54 |
| 2025Q3 | 0% | -1.63 |
| 2025Q2 | 0% | -13.56 |
MLTX
Price: $15.87
52 week price:
Earnings Per Share: -3.84 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.4 billion